The cost of headache disorders in Europe: The Eurolight project

European Journal of Neurology

Volumn 19, Issue 5, 2012, Pages 703-711

  Linde, M ^a,b   Gustavsson, A ^c   Stovner, L J ^a,b   Steiner, T J ^a,d   Barre J ^e   Katsarava, Z ^f   Lainez, J M ^g   Lampl, C ^h   Lanteri Minet M ⁱ   Rastenyte, D ^j   Ruiz de la Torre, E ^k   Tassorelli, C ^l   Andree C ^d,m  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c i3 Innovus   (Sweden)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^f UNIVERSITY OF DUISBURG ESSEN   (Germany)

^g HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^h KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Austria)

ⁱ UNIVERSITY HOSPITAL OF NICE   (France)

^j LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

^k Asociacion Española de Pacientes con Cefalea AEPAC   (Spain)

^l UNIVERSITY OF PAVIA   (Italy)

^m UNIVERSITY OF BASEL   (Switzerland)

more..

Author keywords

Cost; Economic burden; Eurolight; Headache; Migraine

Indexed keywords

ADULT; ARTICLE; COST OF ILLNESS; CROSS-SECTIONAL STUDY; EUROPE; FEMALE; HEADACHE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MONEY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; COST OF ILLNESS; COSTS AND COST ANALYSIS; CROSS-SECTIONAL STUDIES; EUROPE; FEMALE; HEADACHE DISORDERS; HEALTH CARE COSTS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

EID: 84859815299     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2011.03612.x     Document Type: Article

References (31)

1. Stovner LJ, Andree C. Prevalence of headache in Europe: a review for the Eurolight project. J Headache Pain 2010; 11: 289-299.
2. Andlin-Sobocki P, Jonsson B, Wittchen HU, Olesen J. Cost of disorders of the brain in Europe. Eur J Neurol 2005; 12(Suppl. 1): 1-27.
3. Berg J. Economic evidence in migraine and other headaches: a review. Eur J Health Econ 2004; 5(Suppl. 1): S43-S54.
4. Stovner LJ, Andree C. Impact of headache in Europe: a review for the Eurolight project. J Headache Pain 2008; 9: 139-146.
5. Berg J, Stovner LJ. Cost of migraine and other headaches in Europe. Eur J Neurol 2005; 12(Suppl. 1): 59-62.
6. Andrée C, Stovner LJ, Steiner TJ, et al. The Eurolight project: the impact of primary headache disorders in Europe. Description of methods. J Headache Pain 2011; 12: 541-549.
7. Andrée C, Vaillant M, Barre J, et al. Development and validation of the EUROLIGHT questionnaire to evaluate the burden of primary headache disorders in Europe. Cephalalgia 2010; 30: 1082-1100.
8. Headache Classification Subcommittee of the International Headache Society. The International Classification of headache disorders. Cephalalgia 2004; 24(Suppl. 1): 1-160.
9. Eurostat. Average gross annual earnings in industry and services, by gender. URL: Accessed Nov 15, 2010.
10. Luce BR, Elixhauser A. Estimating costs in the economic evaluation of medical technologies. Int J Technol Assess Health Care 1990; 6: 57-75.
11. Stewart WF, Lipton RB, Kolodner KB, Sawyer J, Lee C, Liberman JN. Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain 2000; 88: 41-52.
12. Munakata J, Hazard E, Serrano D, et al. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache 2009; 49: 498-508.
13. Eurostat. Yearbook 2010. URL: Accessed Jan 10, 2011.
14. Jönsson B. General principles of disease-costing. In: Olesen J, Steiner T, Lipton R, eds. Reducing the Burden of Headache. Oxford: Oxford University Press, 2003: 211-217.
15. Kernick D. An introduction to the basic principles of health economics for those involved in the development and delivery of headache care. Cephalalgia 2005; 25: 709-714.
16. Evers S, Afra J, Frese A, et al. EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force. Eur J Neurol 2009; 16: 968-981.
17. Jones G. How often were you absent? A review of the use of self-reported absence data J Appl Psychol 1994; 79: 574-591.
18. Harrisson D, Shaffer M. Comparative examinations of self-reports and perceived absenteeism norms: wading through lake Wobegon. J Appl Psychol 1994; 79: 240-251.
19. Linde M, Dahlof C. Attitudes and burden of disease among self-considered migraineurs--a nation-wide population-based survey in Sweden. Cephalalgia 2004; 24: 455-465.
20. Mennini FS, Gitto L, Martelletti P. Improving care through health economics analyses: cost of illness and headache. J Headache Pain 2008; 9: 199-206.
21. Stovner LJ, Hagen K. Prevalence, burden, and cost of headache disorders. Curr Opin Neurol 2006; 19: 281-285.
22. Láinez J. Prevalencia de la migraña en el medio laboral y su repercusiónn económica. Rev Esp Med Trab 1995; 4: 3-9.
23. Hu XH, Markson LE, Lipton RB, Stewart WF, Berger ML. Burden of migraine in the United States: disability and economic costs. Arch Intern Med 1999; 159: 813-818.
24. Badia X, Magaz S, Gutierrez L, Galvan J. The burden of migraine in Spain: beyond direct costs. Pharmacoeconomics 2004; 22: 591-603.
25. Pop PH, Gierveld CM, Karis HA, Tiedink HG. Epidemiological aspects of headache in a workplace setting and the impact on the economic loss. Eur J Neurol 2002; 9: 171-174.
26. Pradalier A, Auray JP, El Hasnaoui A, et al. Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 study. Pharmacoeconomics 2004; 22: 985-999.
27. Michel P, Dartigues JF, Duru G, Moreau J, Salamon R, Henry P. Incremental absenteeism due to headaches in migraine: results from the Mig-Access French national cohort. Cephalalgia 1999; 19: 503-510.
28. Pugliatti M, Sobocki P, Beghi E, et al. Cost of disorders of the brain in Italy. Neurol Sci 2008; 29: 99-107.
29. Bisdorff A, Sobocki P, Cloos JM, Andree C, Graziano ME. Cost of disorders of the brain in Luxembourg. Bull Soc Sci Med Grand Duche Luxemb 2006; 3: 347-358.
30. van Roijen L, Essink-Bot ML, Koopmanschap MA, Michel BC, Rutten FF. Societal perspective on the burden of migraine in The Netherlands. Pharmacoeconomics 1995; 7: 170-179.
31. Steiner TJ. Headache burdens and bearers. Funct Neurol 2000; 15(Suppl. 3): 219-223.